Immune cells can detect cancer
Now we can see what they see — and help
How I see LJI
A letter from President and CEO Erica Ollmann Saphire, Ph.D.
Letter from the Board Chair – Fall 2021
A letter from Eric Zwisler, Chair, La Jolla Institute for Immunology Board of Directors
Beauty in science
Mexican sculptor assembles an emotional tribute to COVID-19 research
Lynn Hedrick and Klaus Ley named “World Experts” in monocyte research
Immune cells called monocytes offer clues to treating cancers, heart disease and more
Lungs of COVID-19 survivors teem with virus-fighting ‘memory’ cells
Even elderly survivors show a strong, persistent immune memory
Joel Martin named Managing Director and Chief Business Officer at La Jolla Institute for Immunology
LA JOLLA, CA—Joel Martin, Ph.D., MBA, has joined La Jolla Institute for Immunology (LJI) as Managing Director and Chief Business
From Alpha to Epsilon: Consortium study illuminates surfaces of Spike most resistant to antibody escape
LJI-led Coronavirus Immunotherapeutic Consortium identifies antibody 'communities' with power to stop SARS-CoV-2 variants
Q&A with COVID-19 researcher Daniela Weiskopf
Reflections on nearly two years of non-stop COVID-19 research—and a recent honor from her native Austria
Moderna COVID-19 vaccine spurs lasting immune response
Immune system memory stays strong 6+ months post-vaccination, similar to responses in recovered COVID-19 patients
The immune cell with two faces
Immune cells called ILC1s can help fight viruses. Hui Zhi, Ph.D., is setting out to uncover how they do it.
Shane Crotty achieves “World Expert” status for vaccine research
“Vaccines are probably the most important medicines in the world…”